Literature DB >> 17584326

Paclitaxel-induced cutaneous lupus erythematosus in patients with serum anti-SSA/Ro antibody.

Atsuko Adachi1, Tatsuya Horikawa.   

Abstract

Two women (aged 46 and 56 years) developed annular erythema on their sun-exposed skin, including their forearms and faces, after biweekly i.v. administration of paclitaxel for 3-4 months to treat breast cancer. Both cases showed interface changes of basal keratinocytes and high titers of serum anti-SSA/Ro antibody. The diagnoses of paclitaxel-induced cutaneous lupus erythematosus (LE) were made because the skin eruptions cleared rapidly within 3 weeks after the paclitaxel treatment was discontinued. Paclitaxel is proposed to be a causative agent that can provoke cutaneous LE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17584326     DOI: 10.1111/j.1346-8138.2007.00313.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  8 in total

Review 1.  Dermatological adverse events with taxane chemotherapy.

Authors:  Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal:  Eur J Dermatol       Date:  2016-10-01       Impact factor: 3.328

2.  Drug-induced subacute cutaneous lupus erythematosus associated with nab-paclitaxel therapy.

Authors:  N W D Lamond; T Younis; K Purdy; M S Dorreen
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

3.  Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report.

Authors:  Pia Vihinen; Outi Paija; Atte Kivisaari; Leena Koulu; Heikki Aho
Journal:  J Med Case Rep       Date:  2011-06-27

4.  Cremophor-induced lupus erythematosus-like reaction with taxol administration: a case report and review of the literature.

Authors:  Anthony Q Pham; David Berz; Patricia Karwan; Gerald A Colvin
Journal:  Case Rep Oncol       Date:  2011-10-26

5.  Nab-paclitaxel-associated photosensitivity: report in a woman with non-small cell lung cancer and review of taxane-related photodermatoses.

Authors:  Bryce D Beutler; Philip R Cohen
Journal:  Dermatol Pract Concept       Date:  2015-04-30

6.  Drug-induced subacute cutaneous lupus erythematosus associated with docetaxel chemotherapy: a case report.

Authors:  Noelle Y Wong; Laurie M Parsons; Martin J Trotter; Roger Y Tsang
Journal:  BMC Res Notes       Date:  2014-11-05

Review 7.  Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy.

Authors:  Javad Sharifi-Rad; Cristina Quispe; Jayanta Kumar Patra; Yengkhom Disco Singh; Manasa Kumar Panda; Gitishree Das; Charles Oluwaseun Adetunji; Olugbenga Samuel Michael; Oksana Sytar; Letizia Polito; Jelena Živković; Natália Cruz-Martins; Marta Klimek-Szczykutowicz; Halina Ekiert; Muhammad Iqbal Choudhary; Seyed Abdulmajid Ayatollahi; Bekzat Tynybekov; Farzad Kobarfard; Ana Covilca Muntean; Ioana Grozea; Sevgi Durna Daştan; Monica Butnariu; Agnieszka Szopa; Daniela Calina
Journal:  Oxid Med Cell Longev       Date:  2021-10-18       Impact factor: 6.543

8.  Systemic Lupus Erythematosus Associated with Ovarian Cancer.

Authors:  Mayu Yagita; Saori Hata; Hiromi Miyata; Hiroko Kakita; Tatsuo Tsukamoto; Eri Muso; Masaaki Fujita
Journal:  Intern Med       Date:  2018-10-17       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.